The CJC-1295 ipamorelin 10mg no DAC blend combines two research peptides in one vial. Learn how it works, typical research dosing, and safety facts.
The CJC-1295 ipamorelin 10mg no DAC blend is a research peptide combination that pairs a growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue in a single 10mg vial. The No DAC designation means the CJC-1295 lacks the Drug Affinity Complex, giving it a much shorter half-life than the DAC version. This blend is sold strictly for laboratory research and is not FDA-approved for human use.
What’s Inside a 10mg CJC-1295 No DAC and Ipamorelin Blend?
A standard 10mg blend typically contains 5mg of CJC-1295 without DAC and 5mg of ipamorelin, though some vendors use different ratios. The vial usually arrives as a lyophilized powder that requires reconstitution with bacteriostatic water. Each component has a distinct mechanism of action.
- CJC-1295 without DAC (also called Mod GRF 1-29) is a GHRH analog that binds to GHRH receptors in the pituitary, prompting growth hormone release.
- Ipamorelin is a pentapeptide ghrelin mimetic that stimulates the ghrelin receptor. It is known for being highly selective, with minimal impact on cortisol or prolactin in research models.
How CJC-1295 Without DAC and Ipamorelin Work Together
CJC-1295 without DAC and ipamorelin act on different receptors, so they can amplify the same growth hormone pulse. The GHRH analog primes the pituitary, while ipamorelin triggers a stronger, more selective release. Researchers study this synergy because it mimics the body's natural pulsatile GH secretion more closely than either peptide alone.
The short half-life of CJC-1295 without DAC (roughly 30 minutes) means the blend produces brief, discrete GH pulses rather than a sustained elevation. That pattern is often preferred in studies looking at endogenous GH rhythm.
CJC-1295 With DAC vs Without DAC: A Comparison
Understanding the difference between the two CJC-1295 forms is essential when interpreting research results.
| Feature | CJC-1295 with DAC | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|---|
| Half-life | About 6–8 days | About 30 minutes |
| Dosing frequency in research | Once weekly or less | 1–3 times daily |
| GH release pattern | Extended, sustained elevation | Pulsatile, short bursts |
| Albumin binding | Yes | No |
| Common research focus | Steady IGF-1 changes | Natural GH pulse mimicry |
Because the no DAC version clears quickly, it is usually paired with a secretagogue like ipamorelin to create a sharper GH pulse. The DAC version is studied for longer-acting effects but is less useful for pulse-timing experiments.
Typical Research Protocol and Dosage Considerations
All dosage information for peptides is for research purposes only; no human dose is established or approved. In published animal studies and community discussions, a common research starting point is 100–300 mcg of each peptide per injection, given 1–3 times daily. A cjc-1295 no dac ipamorelin 10mg blend dosage chart often suggests timing doses around fasting periods or before sleep to align with natural GH rhythms.
Many researchers also look into the cjc 1295 no dac and ipamorelin blend for its synergistic effect on GH pulses. Online forums such as cjc 1295 no dac ipamorelin reddit threads frequently debate timing, reconstitution volume, and cycle length. A typical cjc-1295 no dac ipamorelin protocol may involve subcutaneous administration, but this is not a clinical recommendation.
Some studies compare sermorelin vs cjc-1295 no dac ipamorelin to determine which GHRH analog is more suitable for a given model. Sermorelin has a shorter half-life than CJC-1295 without DAC, while ipamorelin adds ghrelin-receptor activity. The choice depends on the research question and the desired GH release profile.
Safety, Legal Status, and Sourcing
CJC-1295 without DAC and ipamorelin are not approved by the FDA for human use in the United States. They are sold as research chemicals, not dietary supplements or medications. Buyers should look for third-party certificates of analysis (COA) confirming purity and identity.
In research settings, potential effects include injection site reactions and changes in GH or IGF-1 levels. Because these peptides influence hormone pathways, self-administration without medical supervision carries unknown risks. Anyone with questions about human use should consult a licensed healthcare professional; however, no healthcare provider can legally prescribe these peptides for human consumption in the US.
Legal status varies by country. In the US, importing or possessing these peptides for personal use may violate FDA regulations. Researchers must follow institutional and local laws.
Key Takeaways
- The CJC-1295 ipamorelin 10mg no DAC blend combines a short-acting GHRH analog with a selective GH secretagogue in one vial.
- No DAC means the CJC-1295 has a half-life of about 30 minutes, producing pulsatile GH release rather than sustained elevation.
- Standard research ratios are often 5mg CJC-1295 no DAC to 5mg ipamorelin, but ratios vary by vendor.
- This blend is not FDA-approved for human use and is intended for laboratory research only.
- Consult a healthcare professional for any questions about human hormone therapies.
Frequently Asked Questions
What is a CJC-1295 ipamorelin 10mg no DAC blend?
It is a research peptide combination that contains CJC-1295 without the Drug Affinity Complex and ipamorelin in a single 10mg vial. Most blends use a 5mg/5mg ratio. The product is sold for laboratory research only and is not approved for human use.
How is CJC-1295 no DAC different from CJC-1295 with DAC?
CJC-1295 no DAC has a half-life of about 30 minutes, while the DAC version lasts 6–8 days. The shorter half-life produces pulsatile growth hormone release instead of a sustained elevation. This makes the no DAC form better suited for studies that mimic natural GH pulses.
Is CJC-1295 ipamorelin legal or FDA-approved?
No, the CJC-1295 ipamorelin blend is not FDA-approved for human use in the United States. It is sold as a research chemical and is not a dietary supplement or prescription drug. Anyone considering human use should consult a healthcare professional, though no legal prescription exists for this purpose.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.